6041 - 6050 of 7877 Results
Title
Year
- Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trials2017RESTRICTEDTitle: Biomarker‐driven phenotyping in Parkinson's disease: A translational missing link in disease‐modifying clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 319End Page: 324Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26913Best OA location URL: https://ri.conicet.gov.ar/bitstream/11336/40514/5/CONICET_Digital_Nro.82df6a72-6ca0-4e97-82ab-71e013c4c8bf_s.pdfCitation Count: 148
-
OPENTitle: Multi-modal and targeted imaging improves automated mid-brain segmentationJournal Name: SPIE ProceedingsPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2254428Best OA location URL: https://europepmc.org/articles/pmc5544135?pdf=renderCitation Count: 2
-
OPENTitle: Multi-scale hippocampal parcellation improves atlas-based segmentation accuracyJournal Name: SPIE ProceedingsPublisher: SPIEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1117/12.2254425Best OA location URL: https://europepmc.org/articles/pmc5544133?pdf=renderCitation Count: 10
-
OPENTitle: Red hair, MC1R variants, and risk for Parkinson's disease – a meta‐analysisJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 3Start Page: 212End Page: 216Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.381Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.381Citation Count: 25
-
OPENTitle: Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's DiseaseJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 6Start Page: 578End Page: 585Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205014666170203093219Best OA location URL: https://europepmc.org/articles/pmc6091859?pdf=renderCitation Count: 11
-
RESTRICTEDTitle: Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein ProximityJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 6Issue #: 6Start Page: 921End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.6b00255Citation Count: 12
-
RESTRICTEDTitle: Post translational modification of ParkinJournal Name: Biology DirectPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13062-017-0176-3Best OA location URL: https://biologydirect.biomedcentral.com/track/pdf/10.1186/s13062-017-0176-3Citation Count: 43
- Classification of brain disease in magnetic resonance images using two-stage local feature fusion2017OPENTitle: Classification of brain disease in magnetic resonance images using two-stage local feature fusionJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 2Start Page: e0171749End Page: e0171749Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0171749Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171749&type=printableCitation Count: 13
-
OPENTitle: Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0051-5Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0051-5Citation Count: 77
- A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned2017RESTRICTEDTitle: A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learnedJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 37Issue #:Start Page: 101End Page: 105Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.02.003Citation Count: 31